Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Abhik Das, PhD
RTI International
Principal Investigator - Beena Sood, MD
Wayne State University
Principal Investigator - C. Michael Cotten, MD
Duke University
Principal Investigator - Jonathan M Klein, MD
University of Iowa
Principal Investigator - Krisa P Van Meurs, MD
Stanford University
Principal Investigator - Leif Nelin, MD
Research Institute at Nationwide Children's Hospital
Principal Investigator - Martin Keszler, MD
Brown University, Women & Infants Hospital of Rhode Island
Principal Investigator - Namasivayam Ambalavanan, MD
University of Alabama at Birmingham
Principal Investigator - Pablo J Sanchez, MD
University of Texas, Southwestern Medical Center at Dallas
Principal Investigator - Robin Ohls, MD
University of New Mexico
Principal Investigator - Satyan Lakshminrusimha, MD
University of Rochester
Principal Investigator - Uday Devaskar, MD
University of California, Los Angeles
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California - Los Angeles
Los Angeles, California, United States
- Stanford University
Palo Alto, California, United States
- University of Iowa
Iowa City, Iowa, United States
- Wayne State University
Detroit, Michigan, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- University of Rochester
Rochester, New York, United States
- Duke University
Durham, North Carolina, United States
- Research Institute at Nationwide Children'S Hospital
Columbus, Ohio, United States
- Brown University, Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States
- University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 31 May 2012
- Completion
- 30 Jun 2012
- Last update posted
- 24 Apr 2019
- Registered enrollment
- 7
- Registry id
- NCT01467076
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.